Kim Forest Enterprise Co (金萬林), which focuses on molecular testing, reported that its revenue for the previous quarter grew 2.37 times from a year earlier to NT$212.29 million (US$7.57 million) on the back of strong demand for COVID-19 testing.
That buoyed cumulative revenue for the first three quarters of this year to NT$458 million, up 121 percent from a year earlier, the company said in a statement last week.
Local COVID-19 infections have slowed since July. However, demand for testing kits remains strong at hospitals and testing centers, the company said, adding that people working at hospitals, healthcare institutions and airports need to take tests routinely.
Demand for testing kits remains at a comparatively high level and has been robust enough for Kim Forest to achieve economies of scale, it added.
Kim Forest reported gross margin of 41.88 percent in the first half of this year, up from 22.31 percent a year earlier.
Net profit in the first half was NT$34.8 million, ending three years of net losses, with earnings per share of NT$1.18, it said.
Separately, vaccine maker Adimmune Corp (國光生技) last week posted revenue of NT$464 million for last month, up 3.84 percent from a year earlier. That boosted its third-quarter revenue to NT$753 million, an annual increase of 22 percent.
The company attributed the growth to sales of its quadrivalent flu vaccines in Taiwan and to US-based Protein Sciences Corp.
While revenue in the first nine months fell 19 percent year-on-year to NT$848 million due to a high comparison base last year, the company expects revenue for this quarter to be higher than last quarter as the company would be delivering more flu vaccines to the government, it said.
Meanwhile, TTY Biopharm Co Ltd (台灣東洋藥品), another flu vaccine provider, reported that its revenue for last month dropped 4.65 percent year-on-year to NT$389 million, but its cumulative revenue from January to last month rose 1.6 percent to NT$3.06 billion.
TECH RACE: The Chinese firm showed off its new Mate XT hours after the latest iPhone launch, but its price tag and limited supply could be drawbacks China’s Huawei Technologies Co (華為) yesterday unveiled the world’s first tri-foldable phone, as it seeks to expand its lead in the world’s biggest smartphone market and steal the spotlight from Apple Inc hours after it debuted a new iPhone. The Chinese tech giant showed off its new Mate XT, which users can fold three ways like an accordion screen door, during a launch ceremony in Shenzhen. The Mate XT comes in red and black and has a 10.2-inch display screen. At 3.6mm thick, it is the world’s slimmest foldable smartphone, Huawei said. The company’s Web site showed that it has garnered more than
CROSS-STRAIT TENSIONS: The US company could switch orders from TSMC to alternative suppliers, but that would lower chip quality, CEO Jensen Huang said Nvidia Corp CEO Jensen Huang (黃仁勳), whose products have become the hottest commodity in the technology world, on Wednesday said that the scramble for a limited amount of supply has frustrated some customers and raised tensions. “The demand on it is so great, and everyone wants to be first and everyone wants to be most,” he told the audience at a Goldman Sachs Group Inc technology conference in San Francisco. “We probably have more emotional customers today. Deservedly so. It’s tense. We’re trying to do the best we can.” Huang’s company is experiencing strong demand for its latest generation of chips, called
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Vanguard International Semiconductor Corp (世界先進) and Episil Technologies Inc (漢磊) yesterday announced plans to jointly build an 8-inch fab to produce silicon carbide (SiC) chips through an equity acquisition deal. SiC chips offer higher efficiency and lower energy loss than pure silicon chips, and they are able to operate at higher temperatures. They have become crucial to the development of electric vehicles, artificial intelligence data centers, green energy storage and industrial devices. Vanguard, a contract chipmaker focused on making power management chips and driver ICs for displays, is to acquire a 13 percent stake in Episil for NT$2.48 billion (US$77.1 million).
RSS